| MolName | N-(3-bromophenyl)-2-[1-[3-[(5E)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]propanoyl]benzimidazol-2-yl]sulfanylacetamide |
| MolecularFormula | C26H19N4O3BrS4 |
| Smiles | O=C(CSc1nc(cccc2)c2n1C(CCN(C(/C(/S1)=C\c2cccs2)=O)C1=S)=O)Nc1cccc(Br)c1 |
| InChI | InChI=1S/C26H19BrN4O3S4/c27-16-5-3-6-17(13-16)28-22(32)15-37-25-29-19-8-1-2-9-20(19)31(25)23(33)10-11-30-24(34)21(38-26(30)35)14-18-7-4-12-36-18/h1-9,12-14H,10-11,15H2,(H,28,32) |
| InChIK | ZAUDFQMVPQHKHV-UHFFFAOYSA-N |
| TotalMolweight | 643.63 |
| Molweight | 643.63 |
| MonoisotopicMass | 641.952332 |
| CLogP | 4.896 |
| CLogS | -7.301 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 425.1 |
| Relative PSA | 0.36535 |
| PolarSurfaceArea | 195.23 |
| Druglikeness | 3.7838 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.52632 |
| Fragments | 1 |
| Non HAtoms | 38 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| Rotatable Bond | 9 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 20 |
| Sp3Atoms | 6 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - N-(3-bromophenyl)-2-[1-[3-[(5E)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]propanoyl]benzimidazol-2-yl]sulfanylacetamide | 2 - N-(3-bromophenyl)-2-[1-[3-[(5E)-4-oxo-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-thiazolidin-3-yl]propanoyl]benzimidazol-2-yl]sulfanylacetamide